2gvl

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="2gvl" size="450" color="white" frame="true" align="right" spinBox="true" caption="2gvl, resolution 2.10&Aring;" /> '''Crystal Structure of...)
Line 1: Line 1:
-
[[Image:2gvl.gif|left|200px]]<br /><applet load="2gvl" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:2gvl.gif|left|200px]]<br /><applet load="2gvl" size="350" color="white" frame="true" align="right" spinBox="true"
caption="2gvl, resolution 2.10&Aring;" />
caption="2gvl, resolution 2.10&Aring;" />
'''Crystal Structure of Murine NMPRTase'''<br />
'''Crystal Structure of Murine NMPRTase'''<br />
==Overview==
==Overview==
-
Nicotinamide phosphoribosyltransferase (NMPRTase) has a crucial role in, the salvage pathway of NAD+ biosynthesis, and a potent inhibitor of, NMPRTase, FK866, can reduce cellular NAD+ levels and induce apoptosis in, tumors. We have determined the crystal structures at up to 2.1-A, resolution of human and murine NMPRTase, alone and in complex with the, reaction product nicotinamide mononucleotide or the inhibitor FK866. The, structures suggest that Asp219 is a determinant of substrate specificity, of NMPRTase, which is confirmed by our mutagenesis studies. FK866 is bound, in a tunnel at the interface of the NMPRTase dimer, and mutations in this, binding site can abolish the inhibition by FK866. Contrary to current, knowledge, the structures show that FK866 should compete directly with the, nicotinamide substrate. Our structural and biochemical studies provide a, starting point for the development of new anticancer agents.
+
Nicotinamide phosphoribosyltransferase (NMPRTase) has a crucial role in the salvage pathway of NAD+ biosynthesis, and a potent inhibitor of NMPRTase, FK866, can reduce cellular NAD+ levels and induce apoptosis in tumors. We have determined the crystal structures at up to 2.1-A resolution of human and murine NMPRTase, alone and in complex with the reaction product nicotinamide mononucleotide or the inhibitor FK866. The structures suggest that Asp219 is a determinant of substrate specificity of NMPRTase, which is confirmed by our mutagenesis studies. FK866 is bound in a tunnel at the interface of the NMPRTase dimer, and mutations in this binding site can abolish the inhibition by FK866. Contrary to current knowledge, the structures show that FK866 should compete directly with the nicotinamide substrate. Our structural and biochemical studies provide a starting point for the development of new anticancer agents.
==About this Structure==
==About this Structure==
-
2GVL is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Active as [http://en.wikipedia.org/wiki/Nicotinamide_phosphoribosyltransferase Nicotinamide phosphoribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.12 2.4.2.12] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2GVL OCA].
+
2GVL is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Active as [http://en.wikipedia.org/wiki/Nicotinamide_phosphoribosyltransferase Nicotinamide phosphoribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.12 2.4.2.12] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2GVL OCA].
==Reference==
==Reference==
Line 14: Line 14:
[[Category: Nicotinamide phosphoribosyltransferase]]
[[Category: Nicotinamide phosphoribosyltransferase]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Khan, J.A.]]
+
[[Category: Khan, J A.]]
[[Category: Tao, X.]]
[[Category: Tao, X.]]
[[Category: Tong , L.]]
[[Category: Tong , L.]]
Line 23: Line 23:
[[Category: visfatin]]
[[Category: visfatin]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 11:24:59 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:35:51 2008''

Revision as of 15:35, 21 February 2008


2gvl, resolution 2.10Å

Drag the structure with the mouse to rotate

Crystal Structure of Murine NMPRTase

Overview

Nicotinamide phosphoribosyltransferase (NMPRTase) has a crucial role in the salvage pathway of NAD+ biosynthesis, and a potent inhibitor of NMPRTase, FK866, can reduce cellular NAD+ levels and induce apoptosis in tumors. We have determined the crystal structures at up to 2.1-A resolution of human and murine NMPRTase, alone and in complex with the reaction product nicotinamide mononucleotide or the inhibitor FK866. The structures suggest that Asp219 is a determinant of substrate specificity of NMPRTase, which is confirmed by our mutagenesis studies. FK866 is bound in a tunnel at the interface of the NMPRTase dimer, and mutations in this binding site can abolish the inhibition by FK866. Contrary to current knowledge, the structures show that FK866 should compete directly with the nicotinamide substrate. Our structural and biochemical studies provide a starting point for the development of new anticancer agents.

About this Structure

2GVL is a Single protein structure of sequence from Mus musculus. Active as Nicotinamide phosphoribosyltransferase, with EC number 2.4.2.12 Full crystallographic information is available from OCA.

Reference

Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents., Khan JA, Tao X, Tong L, Nat Struct Mol Biol. 2006 Jul;13(7):582-8. Epub 2006 Jun 18. PMID:16783377

Page seeded by OCA on Thu Feb 21 17:35:51 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools